← Alle mensen

FD

Franck Dubin

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Isatuximab plus PomDex versus PomDex bij myeloom: ICARIA-MM definitieve OS

The Lancet. Oncology · 2022-03

Isatuximab plus pomalidomide-dexamethason versus pomalidomide-dexamethason bij recidief myeloom: ICARIA-MM fase III

Lancet (London, England) · 7 december 2019